J. Team Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
6,294
+64
+1% +$3.67K 0.35% 60
2026
Q1
$378K Sell
6,230
-833
-12% -$48.6K 0.42% 50
2025
Q4
$381K Sell
7,063
-615
-8% -$29.6K 0.38% 52
2025
Q3
$346K Buy
+7,678
New +$359K 0.35% 55

Other funds holding BMY

J. Team Financial's BMY Position: Q2 2026 in Review

J. Team Financial increased its Bristol-Myers Squibb (BMY) stake by 1% in Q2 2026, buying an estimated $3.67K and bringing the position to 6,294 shares worth $363K. The position accounts for 0.35% of the portfolio, ranked #60.

J. Team Financial first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $381K in Q4 2025. 1,501 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • J. Team Financial held 6,294 shares of Bristol-Myers Squibb worth $363K as of Q2 2026.
  • J. Team Financial bought 64 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.67K.
  • Bristol-Myers Squibb made up 0.35% of J. Team Financial's portfolio in Q2 2026, its #60 holding.
  • J. Team Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • J. Team Financial's Bristol-Myers Squibb position peaked at $381K in Q4 2025.
  • 1,501 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on J. Team Financial's 13F filing for Q2 2026, filed 27 Jul 2026.